|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments in securities: | ||||||||||||||||||||
| Fixed maturity securities, available-for-sale, at fair value (amortized cost: June 30, 2026: $130,458; December 31, 2025: $116,852) | ||||||||||||||||||||
| Equity securities, cost | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Premiums and fees receivable | ||||||||||||||||||||
| Accrued interest and dividends | ||||||||||||||||||||
| Prepaid expenses and other receivables | ||||||||||||||||||||
| Property, net | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Lease assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Current income taxes recoverable | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Reserve for claims | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Current income taxes payable | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Preferred stock (1,000 authorized shares; no shares issued) | ||||||||||||||||||||
| Common stock – no par value (10,000 authorized shares; 1,888 and 1,888 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively, excluding in each period 292 shares of common stock held by the Company) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
